150 related articles for article (PubMed ID: 34815362)
1. Intensified partner notification and repeat testing can improve the effectiveness of screening in reducing
Hui BB; Hocking JS; Braat S; Donovan B; Fairley CK; Guy R; Spark S; Yeung A; Low N; Regan D
Sex Transm Infect; 2022 Sep; 98(6):414-419. PubMed ID: 34815362
[TBL] [Abstract][Full Text] [Related]
2. Accelerated partner therapy (APT) partner notification for people with
Estcourt CS; Howarth AR; Copas A; Low N; Mapp F; Woode Owusu M; Flowers P; Roberts T; Mercer CH; Wayal S; Symonds M; Nandwani R; Saunders J; Johnson AM; Pothoulaki M; Althaus C; Pickering K; McKinnon T; Brice S; Comer A; Tostevin A; Ogwulu CD; Vojt G; Cassell JA
BMJ Open; 2020 Mar; 10(3):e034806. PubMed ID: 32229523
[TBL] [Abstract][Full Text] [Related]
3. Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
Guy RJ; Ward J; Causer LM; Natoli L; Badman SG; Tangey A; Hengel B; Wand H; Whiley D; Tabrizi SN; Shephard M; Fairley CK; Donovan B; Anderson DA; Regan DG; Maher L; Kaldor JM
Lancet Infect Dis; 2018 Oct; 18(10):1117-1126. PubMed ID: 30303108
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling.
Althaus CL; Turner KM; Mercer CH; Auguste P; Roberts TE; Bell G; Herzog SA; Cassell JA; Edmunds WJ; White PJ; Ward H; Low N
Health Technol Assess; 2014 Jan; 18(2):1-100, vii-viii. PubMed ID: 24411488
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.
Low N; McCarthy A; Macleod J; Salisbury C; Campbell R; Roberts TE; Horner P; Skidmore S; Sterne JA; Sanford E; Ibrahim F; Holloway A; Patel R; Barton PM; Robinson SM; Mills N; Graham A; Herring A; Caul EO; Davey Smith G; Hobbs FD; Ross JD; Egger M;
Health Technol Assess; 2007 Mar; 11(8):iii-iv, ix-xii, 1-165. PubMed ID: 17311735
[TBL] [Abstract][Full Text] [Related]
6. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
Hocking JS; Temple-Smith M; Guy R; Donovan B; Braat S; Law M; Gunn J; Regan D; Vaisey A; Bulfone L; Kaldor J; Fairley CK; Low N;
Lancet; 2018 Oct; 392(10156):1413-1422. PubMed ID: 30343857
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening young men for
Qu Z; Azizi A; Schmidt N; Craig-Kuhn MC; Stoecker C; Hyman JM; Kissinger PJ
BMJ Open; 2021 Jan; 11(1):e040789. PubMed ID: 33483442
[TBL] [Abstract][Full Text] [Related]
8. Accelerated partner therapy contact tracing for people with chlamydia (LUSTRUM): a crossover cluster-randomised controlled trial.
Estcourt CS; Stirrup O; Copas A; Low N; Mapp F; Saunders J; Mercer CH; Flowers P; Roberts T; Howarth AR; Owusu MW; Symonds M; Nandwani R; Ogwulu C; Brice S; Johnson AM; Althaus CL; Williams E; Comer-Schwartz A; Tostevin A; Cassell JA
Lancet Public Health; 2022 Oct; 7(10):e853-e865. PubMed ID: 36182235
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model.
Rönn MM; Tuite AR; Menzies NA; Wolf EE; Gift TL; Chesson HW; Torrone E; Berruti A; Mazzola E; Galer K; Hsu K; Salomon JA
Am J Epidemiol; 2019 Mar; 188(3):545-554. PubMed ID: 30608525
[TBL] [Abstract][Full Text] [Related]
10. Individual and population level effects of partner notification for Chlamydia trachomatis.
Althaus CL; Heijne JC; Herzog SA; Roellin A; Low N
PLoS One; 2012; 7(12):e51438. PubMed ID: 23251534
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis testing in the second British national survey of sexual attitudes and lifestyles: respondent uptake and treatment outcomes.
McCadden A; Fenton KA; McManus S; Mercer CH; Erens B; Carder C; Ridgway G; Macdowall W; Nanchahal K; Byron CL; Copas A; Wellings K; Johnson AM
Sex Transm Dis; 2005 Jun; 32(6):387-94. PubMed ID: 15912087
[TBL] [Abstract][Full Text] [Related]
12. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study.
Turner K; Adams E; Grant A; Macleod J; Bell G; Clarke J; Horner P
BMJ; 2011 Jan; 342():c7250. PubMed ID: 21205807
[TBL] [Abstract][Full Text] [Related]
13. Developments in the screening for Chlamydia trachomatis: a review.
Kohl KS; Markowitz LE; Koumans EH
Obstet Gynecol Clin North Am; 2003 Dec; 30(4):637-58. PubMed ID: 14719842
[TBL] [Abstract][Full Text] [Related]
14. The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.
Smith KS; Kaldor JM; Hocking JS; Jamil MS; McNulty AM; Read P; Bradshaw CS; Chen MY; Fairley CK; Wand H; Worthington K; Blake S; Knight V; Rawlinson W; Saville M; Tabrizi SN; Garland SM; Donovan B; Guy R
BMC Public Health; 2016 Jan; 16():83. PubMed ID: 26822715
[TBL] [Abstract][Full Text] [Related]
15. Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study.
Kretzschmar M; Satterwhite C; Leichliter J; Berman S
Sex Transm Dis; 2012 May; 39(5):325-31. PubMed ID: 22504590
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests.
Smith KS; Hocking JS; Chen M; Fairley CK; McNulty A; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy R
BMC Infect Dis; 2014 Apr; 14():223. PubMed ID: 24758169
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.
van den Broek IV; van Bergen JE; Brouwers EE; Fennema JS; Götz HM; Hoebe CJ; Koekenbier RH; Kretzschmar M; Over EA; Schmid BV; Pars LL; van Ravesteijn SM; van der Sande MA; de Wit GA; Low N; Op de Coul EL
BMJ; 2012 Jul; 345():e4316. PubMed ID: 22767614
[TBL] [Abstract][Full Text] [Related]
18. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study.
Kretzschmar M; Turner KM; Barton PM; Edmunds WJ; Low N
Sex Transm Infect; 2009 Sep; 85(5):359-66. PubMed ID: 19454407
[TBL] [Abstract][Full Text] [Related]
19. Reinfection by untreated partners of people treated for Chlamydia trachomatis and Neisseria gonorrhoeae: mathematical modelling study.
Low N; Heijne JC; Herzog SA; Althaus CL
Sex Transm Infect; 2014 May; 90(3):254-6. PubMed ID: 24448560
[TBL] [Abstract][Full Text] [Related]
20. The chlamydia knowledge, awareness and testing practices of Australian general practitioners and practice nurses: survey findings from the Australian chlamydia control effectiveness pilot (ACCEPt).
Lorch R; Hocking J; Temple-Smith M; Law M; Yeung A; Wood A; Vaisey A; Donovan B; Fairley CK; Kaldor J; Guy R
BMC Fam Pract; 2013 Nov; 14():169. PubMed ID: 24219113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
